Drug news
EU approves Zyclara (Meda AB) for Actinic Keratoses
Meda AB has announced that the European Commission (EC) has granted marketing authorization for Zyclara (imiquimod 3.75% cream) in the European Union. Zyclara is a patented product for the treatment of Actinic Keratosis. The approval is valid in all EU countries.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.